In Vitro Diagnostics (IVD) Quality Control Product Market by Product Type (Quality Controls (Whole Blood-based Controls, Serum/Plasma-based Controls, Urine-based Controls), by Manufacturer Type [Instrument Manufacturer Controls and Independent Manufacturer Controls (Third-party Controls and Instrument Manufacturer Controls)] - Global Opportunity Analysis and Industry Forecast, 2014-2022

Code: ALLI-Auto-2Z78

Report

November 2019

Pages:170

Allied Market Research

Description

Table of Content

Tables & Figures

IVD Quality Control Product Market Overview:

The global IVD quality control products market was valued at $823 million in 2015, and is expected to reach $1,052 million by 2022, registering a CAGR of 3.5% from 2016 to 2022.

In-vitro diagnostics (IVD) quality controls (QC) are liquid or lyophilized samples or materials, which are used by laboratories to check the testing process to ensure reliability and accuracy of testing results. The regulatory bodies and accredited bodies insist on using quality controls for every test performed in laboratories. However, laboratories use quality controls for testing products when reagent batches are changed, analyzers/instruments are serviced, or test results seem incorrect.

The market is driven by factors such as increase in adoption of third party quality control products, upsurge in the number of laboratories and diagnostic centers worldwide, and stringent norms for using controls. However, poor reimbursement framework and lack of regulations on the use of controls in the emerging economies are projected to hamper the market growth during the analysis period.

The global IVD quality controls products market is segmented based on product type into quality controls, IVD quality control data management software, and IVD quality assurance services. In 2015, the quality controls segment accounted for the largest share in the global market, and is estimated to grow at the fastest CAGR of 3.7% during the analysis period. The market growth is attributed to upsurge in demand for third-party quality control products and services.

The IVD quality controls market is segmented based on application into clinical chemistry, immunochemistry, hematology, molecular diagnostics, coagulation, microbiology, and others. The molecular biology diagnostics segment is estimated to grow at the fastest CAGR of 5.3% during the analysis period. The end users of the market are hospitals, clinical laboratories, research & academic institutes, and others. The hospitals segment held the largest share in the global IVD quality control products market in 2015.

Based on manufacturer type, the market is divided into instrument manufacturer controls and independent manufacturer controls including third party controls and instrument specific controls. The independent manufacturer controls segment dominated the market in 2015, and is estimated to grow at the fastest CAGR during the forecast period, owing to the increase in demand for third party controls.

The global IVD quality control market is segmented on the basis of region into North America, Europe, Asia-Pacific, and LAMEA regions. North America dominated the global market in 2015 due to stringent mandates on the use of third party IVD quality control products by regulatory authorities. The Asia-Pacific and LAMEA regions are expected to provide lucrative opportunities to market players in the near future. Asia-Pacific is expected to be the fastest growing region by 2022, registering a CAGR of 4.9% during the forecast period.

KEY MARKET BENEFITS

In-depth analysis of the market is based on market estimations of key segments for the period of 2014–2022.
Comprehensive analyses of market dynamics, such as drivers, restraints, and opportunities impacting the market growth are provided in the report.
Exhaustive analysis of the market segments helps in understanding the prospects of IVD quality control products and variants in the future.
Competitive intelligence of leading manufacturers and distributors of IVD quality control products market helps in understanding the competitive scenario of geographies.
The profiles and strategies of key market players are provided in the report to understand the competitive outlook of the global market.

KEY MARKET SEGMENT

The global IVD quality control products market is segmented based on product type, application, end user, manufacturer type, and geography.

BY PRODUCT TYPE

Quality Controls
Whole Blood-based Controls
Serum/Plasma-based Controls
Urine-based Controls
Other IVD Quality Controls
Data Management Software
Quality Assurance Services

BY APPLICATION

Clinical Chemistry
Immunochemistry
Hematology
Molecular Diagnostics
Coagulation/Hemostasis
Microbiology
Others

BY END USER

Hospitals
Clinical Laboratories
Research and Academic Institutes
Others

BY MANUFACTURER TYPE

Instrument Manufacturer Controls
Independent Manufacturer Controls
Third-party Controls
Instrument Manufacturer Controls

BY GEOGRAPHY

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Rest of Asia-Pacific
LAMEA
Latin America
Middle East
Africa

KEY PLAYERS

Bio-Rad Laboratories, Inc.
Thermo Fisher Scientific, Inc.
Randox Laboratories Ltd.
Roche Diagnostics
Abbott Diagnostics
Helena Laboratories
Seracare Life Sciences, Inc.
Technopath Clinical Diagnostics
Sun Diagnostics, LLC.

The other players in the industry (profiles not included in the report) include

Zeptometrix Corporation
ISOLAB GmbH
Sysmex Corporation
Fortress Diagnostics
Meril Life Sciences Pvt. Ltd.
Multiplicom N.V.
Future Diagnostics Solutions B.V.
Surmodics, Inc.

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION

1.2. KEY BENEFITS

1.3. KEY MARKET SEGMENTS

1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research

1.4.2. Primary research

1.5. ANALYST TOOLS AND MODELS

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE

3.2. KEY FINDINGS

3.2.1. Top Investment Pockets

3.2.2. Top Winning Strategies

3.3. PORTERS FIVE FORCES ANALYSIS

3.3.1. Bargaining Power Of Suppliers

3.3.2. Bargaining Power Of Buyers

3.3.3. Threat Of New Entrants

3.3.4. Intensity Of Competitive Rivalry

3.3.5. Threat Of Substitutes

3.4. MARKET SHARE ANALYSIS, 2015

3.5. MARKET DYNAMICS

3.6. DRIVERS

3.6.1. Growing number of accredited clinical laboratories

3.6.1.1. Increasing mandates on the use of quality controls from regulatory and accreditation bodies

3.6.1.2. Increasing Adoption of Third-Party multi-analyte Quality Controls

3.6.2. Restraints

3.6.2.1. Stringent regulatory requirements for the approval and commercialization of IVD and their quality control Products

3.6.2.2. Inadequate reimbursement policies for IVD quality control

3.6.3. Opportunities

3.6.3.1. Developing economies offer lucarative growth opportunities

CHAPTER 4 IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE

4.1. OVERVIEW

4.2. QUALITY CONTROLS

4.2.1. Key market trends

4.2.2. Key growth factors and opportunities

4.2.3. Market size and forecast

4.2.4. Whole Blood-Based Controls

4.2.4.1 Market size and forecast

4.2.5. Serum/plasma-based Controls

4.2.5.1. Market size and forecast

4.2.6. Urine-based controls

4.2.6.1. Market size and forecast

4.2.7. Other source-based controls

4.2.7.1. Market size and forecast

4.3. DATA MANAGEMENT SOFTWARE

4.3.1. Key market trends

4.3.2. Key growth factors and opportunities

4.3.3. Market size and forecast

4.4. QUALITY ASSURANCE SERVICES

4.4.1. Key market trends

4.4.2. Key growth factors and opportunities

4.4.3. Market size and forecast

CHAPTER 5 IVD QUALITY CONTROL PRODUCTS MARKET, BY APPLICATION

5.1. OVERVIEW

5.2. CLINICAL CHEMISTRY

5.2.1. Market size and forecast

5.3. IMMUNOASSAY

5.3.1. Market size and forecast

5.4. HEMATOLOGY

5.4.1. Market size and forecast

5.5. MOLECULAR DIAGNOSTICS

5.5.1. Market size and forecast

5.6. COAGULATION/HEMOSTASIS

5.6.1. Market size and forecast

5.7. MICROBIOLOGY

5.7.1. Market size and forecast

CHAPTER 6 IVD QUALITY CONTROL PRODUCTS MARKET, BY MANUFACTURER TYPE

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. INSTRUMENT MANUFACTURER CONTROLS

6.2.1. Market size & forecast

6.3. INDEPENDENT MANUFACTURER CONTROLS

6.3.1. Market size & forecast

6.3.2. Third-party controls

6.3.2.1. Market Size & Forecast

6.3.3. Instrument-Specific Controls

6.3.3.1. Market Size & Forecast

CHAPTER 7 IVD QUALITY CONTROL PRODUCTS MARKET, BY END USER

7.1. OVERVIEW

7.2. CLINICAL LABORATORIES

7.2.1. Market size and forecast

7.3. HOSPITALS

7.3.1. Market size and forecast

7.4. RESEARCH AND ACADEMIC INSTITUTES

7.4.1. Market size and forecast

7.5. OTHERS

7.5.1. Market size and forecast

CHAPTER 8 IVD QUALITY CONTROL PRODUCTS MARKET, BY GEOGRAPHY

8.1. INTRODUCTION

8.1.1. Market size and forecast

8.2. NORTH AMERICA

8.2.1. Key market trends

8.2.2. Key growth factors and opportunities

8.2.3. Market size and forecast

8.2.4. U.S. market size and forecast

8.2.5. Canada market size and forecast

8.2.6. Mexico market size and forecast

8.3. EUROPE

8.3.1. Key market trends

8.3.2. Key growth factors and opportunities

8.3.3. Market size and forecast

8.3.4. Germany market size and forecast

8.3.5. France market size and forecast

8.3.6. UK: market size and forecast

8.3.7. Italy market size and forecast

8.3.8. Rest of Europe: market size and forecast

8.4. ASIA-PACIFIC

8.4.1. Key market trends

8.4.2. Key growth factors and opportunities

8.4.3. Market size and forecast

8.4.4. Japan market size and forecast

8.4.5. China market size and forecast

8.4.6. India market size and forecast

8.4.7. Rest of Asia-Pacific market size and forecast

8.5. LAMEA

8.5.1. Key market trends

8.5.2. Key growth factors and opportunities

8.5.3. Market size and forecast

8.5.4. Latin America market size and forecast

8.5.5. Middle East market size and forecast

8.5.6. Africa market size and forecast

CHAPTER 9 COMPANY PROFILES

9.1. SERACARE LIFE SCIENCES, INC.

9.1.1. Company overview

9.1.2. Operating business segments

9.1.3. Business performance

9.1.4. Key strategic moves and developments

9.2. TECHNOPATH DISTRIBUTION LTD.

9.2.1. Company overview

9.2.2. Operating business segments

9.2.3. Business performance

9.2.4. Key strategic moves and developments

9.3. BIO-RAD LABORATORIES INC.

9.3.1. Company overview

9.3.2. Business operating segments

9.3.3. Business performance

9.3.4. Key strategic moves and developments

9.4. ABBOTT LABORATORIES

9.4.1. Company overview

9.4.2. Operating business segments

9.4.3. Business performance

9.5. DANAHER CORPORATION

9.5.1. Company overview

9.5.2. Operating business segments

9.5.3. Business performance

9.5.4. Key strategic moves and developments

9.6. HELENA LABORATORIES CORPORATION

9.6.1. Company overview

9.6.2. Operating business segments

9.6.3. Business performance

9.7. ORTHO-CLINICAL DIAGNOSTICS, INC.

9.7.1. Company overview

9.7.2. Operating business segments

9.7.3. Business performance

9.7.4. Key strategic moves and developments

9.8. RANDOX LABORATORIES LTD.

9.8.1. Company overview

9.8.2. Operating business segments

9.8.3. Business performance

9.8.4. Key strategic moves and developments

9.9. F. HOFFMANN-LA ROCHE LTD.

9.9.1. Company overview

9.9.2. Operating business segments

9.9.3. Business performance

9.9.4. Key strategic moves and developments

9.10. SUN DIAGNOSTICS, LLC

9.10.1. Company overview

9.10.2. Operating business segments

9.10.3. Sun Diagnostics, LLC.: business segments

9.10.4. Business performanc

TABLE 1. GLOBAL IVD QUALITY CONTROLS PRODUCTS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)

TABLE 2. GLOBAL IVD QUALITY CONTROLS MARKET, BY SOURCE TYPE, 2014-2022 ($MILLION)

TABLE 3. IVD QUALITY CONTROLS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 4. WHOLE BLOOD-BASED QUATILTY CONTROLS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 5. SERUM-BASED QUALITY CONTROLS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 6. URINE-BASED QUALITY CONTROLS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 7. OTHER SOURCE-BASED QUALITY CONTROLS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 8. IVD QUALITY CONTROLS DATA MANAGEMENT SOFTWARE MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 9. IVD QUALITY ASSURANCE SERVICES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 10. GLOBAL IVD QUALITY CONTROLS MARKET, BY APPLICATION, 2014-2022 ($MILLION)

TABLE 11. CLINICAL CHEMISTRY QUATILTY CONTROLS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 12. IMMUNOCHEMISTRY QUATILTY CONTROLS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 13. HEMAOTOLOGY QUATILTY CONTROLS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 14. MOLECULAR DAIGNOSTICS QUATILTY CONTROLS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 15. MICROBIOLOGY QUATILTY CONTROLS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 16. INSTRUMENT MANUFACTURER CONTROLS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)

TABLE 19. GLOBAL IVD QUALITY CONTROL PRODUCTS MARKET, BY END USER, 2015-2022 ($MILLION)

TABLE 20. IVD QUALITY CONTROL PRODUCTS MARKET FOR CLINICAL LABORATORIES, BY GEOGRAPHY, 2015-2022 ($MILLION)

TABLE 21. IVD QUALITY CONTROL PRODUCTS MARKET FOR HOSPITALS, BY GEOGRAPHY, 2015-2022 ($MILLION)

TABLE 22. IVD QUALITY CONTROL PRODUCTS MARKET FOR RESEARCH AND ACADEMIC INSTITUTES, BY GEOGRAPHY, 2015-2022 ($MILLION)

TABLE 23. IVD QUALITY CONTROL PRODUCTS MARKET FOR OTHER END USERS, BY GEOGRAPHY, 2015-2022 ($MILLION)

TABLE 24. IVD QUALITY CONTROL PRODUCTS MARKET, BY GEOGRAPHY, 2015-2022 ($MILLION)

TABLE 25. NORTH AMERICA IVD QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2014-2022 ($MILLION)

TABLE 26. NORTH AMERICA IVD QUALITY CONTROL PRODUCTS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)

TABLE 27. NORTH AMERICA IVD QUALITY CONTROL PRODUCTS MARKET, BY APPLICATION, 2014-2022 ($MILLION)

TABLE 28. NORTH AMERICA IVD QUALITY CONTROL PRODUCTS MARKET, BY END USER, 2014-2022 ($MILLION)

TABLE 29. NORTH AMERICA IVD QUALITY CONTROL PRODUCTS MARKET, BY MANUFACTURER TYPE, 2014-2022 ($MILLION)

TABLE 30. EUROPE IVD QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2014-2022 ($MILLION)

TABLE 31. EUROPE IVD QUALITY CONTROL PRODUCTS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)

TABLE 32. EUROPE IVD QUALITY CONTROL PRODUCTS MARKET, BY APPLICATION, 2014-2022 ($MILLION)

TABLE 33. EUROPE IVD QUALITY CONTROL PRODUCTS MARKET, BY END USER, 2014-2022 ($MILLION)

TABLE 34. EUROPE IVD QUALITY CONTROL PRODUCTS MARKET, BY MANUFACTURER TYPE, 2014-2022 ($MILLION)

TABLE 35. ASIA-PACIFIC IVD QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2014-2022 ($MILLION)

TABLE 36. ASIA-PACIFIC IVD QUALITY CONTROL PRODUCTS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)

TABLE 37. ASIA-PACIFIC IVD QUALITY CONTROL PRODUCTS MARKET, BY APPLICATION, 2014-2022 ($MILLION)

TABLE 38. ASIA-PACIFIC IVD QUALITY CONTROL PRODUCTS MARKET, BY END USER, 2014-2022 ($MILLION)

TABLE 39. ASIA-PACIFIC IVD QUALITY CONTROL PRODUCTS MARKET, BY MANUFACTURER TYPE, 2014-2022 ($MILLION)

TABLE 40. LAMEA IVD QUALITY CONTROL PRODUCTS MARKET, BY REGION, 2014-2022 ($MILLION)

TABLE 41. LAMEA IVD QUALITY CONTROL PRODUCTS MARKET, BY PRODUCT TYPE, 2014-2022 ($MILLION)

TABLE 42. LAMEA IVD QUALITY CONTROL PRODUCTS MARKET, BY APPLICATION, 2014-2022 ($MILLION)

TABLE 43. LAMEA IVD QUALITY CONTROL PRODUCTS MARKET, BY END USER, 2014-2022 ($MILLION)

TABLE 44. LAMEA IVD QUALITY CONTROL PRODUCTS MARKET, BY MANUFACTURER TYPE, 2014-2022 ($MILLION)

TABLE 45. SERACARE LIFE SCIENCES, INC.: COMPANY SNAPSHOT

TABLE 46. SERACARE LIFE SCIENCES, INC.: BUSINESS SEGMENTS

TABLE 47. TECHNOPATH DISTRIBUTION LTD.: COMPANY SNAPSHOT

TABLE 48. TECHNOPATH DISTRIBUTION LTD: BUSINESS SEGMENTS

TABLE 49. BIO-RAD LABORATORIES INC.: COMPANY SNAPSHOT

TABLE 50. BIO-RAD LABORATORIES INC.: BUSINESS SEGMENTS

TABLE 51. ABBOTT: COMPANY SNAPSHOT

TABLE 52. ABBOTT: BUSINESS SEGMENTS

TABLE 53. DANAHER: COMPANY SNAPSHOT

TABLE 54. DANAHER: BUSINESS SEGMENTS

TABLE 55. HELENA LABORATORIES CORPORATION: COMPANY SNAPSHOT

TABLE 56. HELENA LABORATORIES CORPORATION: BUSINESS SEGMENTS

TABLE 57. ORTHO-CLINICAL DIAGNOSTICS: COMPANY SNAPSHOT

TABLE 58. ORTHO-CLINICAL DIAGNOSTICS, INC.: OPERATING SEGMENTS

TABLE 59. RANDOX LABORATORIES: COMPANY SNAPSHOT

TABLE 60. RANDOX LABORATORIES: OPERATING SEGMENTS

TABLE 61. ROCHE: OPERATING SEGMENTS

TABLE 62. SUN DIAGNOSTICS, LLC: COMPANY SNAPSHOT FIGURE 1. TOP INVESTMENT POCKETS

FIGURE 2. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 2014-2016

FIGURE 3. TOP WINNING STRATEGIES: NATURE AND TYPE 2014-2016

FIGURE 4. PORTERS FIVE FORCES ANALYSIS

FIGURE 5. MARKET SHARE ANALYSIS, 2015

FIGURE 6. TOP IMPACTING FACTORS: GLOBAL IVD QUALITY CONTROL PRODUCTS MARKET

FIGURE 7. MEDICAL DEVICE DEVELOPMENT AND APPROVAL PROCEDURE

FIGURE 8. U.S. IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)

FIGURE 9. CANADA IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)

FIGURE 10. MEXICO IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)

FIGURE 11. GERMANY IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)

FIGURE 12. FRANCE IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)

FIGURE 13. UK IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)

FIGURE 14. ITALY IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)

FIGURE 15. REST OF EUROPE IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)

FIGURE 16. JAPAN IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)

FIGURE 17. CHINA IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)

FIGURE 18. INDIA IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)

FIGURE 19. REST OF ASIA-PACIFIC: IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)

FIGURE 20. LATIN AMERICA IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)

FIGURE 21. MIDDLE EAST IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)

FIGURE 22. AFRICA IVD QUALITY CONTROL PRODUCTS MARKET, 2014-2022 ($MILLION)

FIGURE 23. BIO-RAD LABORATORIES INC.: BUSINESS PERFORMANCE

FIGURE 24. ABBOTT REVENUE, 2013-2015 ($MILLION)

FIGURE 25. ABBOTT REVENUE SHARE, BY OPERATING SEGMENT, 2015 (%)

FIGURE 26. ABBOTT REVENUE SHARE, BY GEOGRAPHY, 2015 (%)

FIGURE 27. DANAHER REVENUE, 2013-2015 ($MILLION)

FIGURE 28. DANAHER REVENUE SHARE, BY OPERATING SEGMENT, 2015 (%)

FIGURE 29. DANAHER REVENUE SHARE, BY GEOGRAPHY, 2015(%)

FIGURE 30. ROCHE: REVENUE, 2013-2015 ($MILLION)

FIGURE 31. ROCHE REVENUE SHARE, BY PRODUCT, 2015 (%)

FIGURE 32. ROCHE REVENUE SHARE, BY GEOGRAPHY, 2015 (%

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$6981

This license allows only one user(purchaser of the report) to access the PDF.

Multi User

Electronic (PDF)

$8385

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11693

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Published Date: November 2019

Report Code: ALLI-Auto-2Z78

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-20I14555

Fri Nov 22 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-5F14600

Fri Nov 22 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-37K14129

Fri Nov 22 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-5X14590

Fri Nov 22 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions